首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1918124

伽瑪刀市場－2026-2031年預測

Gamma Knife Market - Forecast from 2026 to 2031

出版日期: 2026年01月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計伽瑪刀市場將從 2025 年的 422,965,000 美元成長到 2031 年的 571,712,000 美元，複合年成長率為 5.15%。

伽瑪刀市場：產業分析

伽瑪刀市場正以 5.15% 的強勁複合年成長率成長，預計到 2031 年將達到 571,712,000 美元。這種專為腦腫瘤和神經系統疾病的非侵入性放射外科手術而設計的專用醫療設備，在全球醫療保健系統中日益受到重視，因為這些系統正在尋求針對複雜神經系統疾病的精準且微創的治療方法方案。

市場促進因素

腦腫瘤的盛行率

腦腫瘤發生率的不斷上升是伽瑪刀市場擴張的主要驅動力。該設備的高精度引導系統和專用準直器能夠將多束放射線精確地聚焦於目標病灶，從而在有效治療的同時，最大限度地減少對健康腦組織的輻射暴露。這種精準性尤其重要，因為腦腫瘤是所有癌症中存活期最短的，平均存活期僅27年。這項能夠以亞毫米級精度標靶腫瘤的技術，正日益成為神經外科醫師和放射腫瘤科醫師治療這些疑難病例的首選。

應用於神經系統疾病

除了腦腫瘤，伽瑪刀放射手術在多種神經系統疾病中也展現出療效，拓展了其臨床效用。該技術透過將輻射聚焦於異常血管來治療某些動靜脈畸形，使其逐漸閉合。此外，伽瑪刀在運動障礙（包括自發性震顫和帕金森氏症）治療方面的潛在應用也正在研究中。在美國，約有4,200萬人受運動障礙影響，因此，治療範圍的擴大顯著提升了市場潛力，並將伽瑪刀技術定位為治療神經系統疾病的多功能工具。

診斷影像軟體整合

影像軟體的進步在提升伽瑪刀治療計劃和實施方面發揮關鍵作用。現代影像平台能夠精確勾勒出標靶病灶，確保手術過程中標靶的準確定位。3D成像功能結合專用演算法和先進工具，有助於制定最佳化的治療計劃，最大限度地提高病灶組織的輻射劑量，同時最大限度地減少對周圍正常組織的輻射暴露。這些技術進步有助於持續改善治療效果，並擴大伽瑪刀放射放射線手術的適用臨床範圍。

人口結構方面的必然要求

人口老化是腦腫瘤和神經系統疾病發生率上升的關鍵促進因素。世界正經歷顯著的人口結構變化，預計60歲及以上人口的比例將從2015年的12%增加到2050年的22%。此外，預計60歲及以上人口將從2020年的10億增加到2031年的14億。這些人口結構變化使得人們對伽瑪刀技術所提供的有效、微創治療方案的需求持續成長。

教育活動

隨著患者和醫護人員對伽瑪刀放射放射線手術益處的認知不斷提高，其應用普及率正在加速成長。教育活動、線上資源和資訊共用平台正在加深人們對這項技術的功能和臨床應用的理解。專門的培訓課程應運而生，旨在支持醫護人員的培養，確保伽瑪刀系統的正確使用，從而促進其在醫療機構中更廣泛的應用。

市場限制

儘管伽瑪刀市場呈現良好的成長趨勢，但仍面臨諸多挑戰。伽瑪刀系統的複雜性和專業性意味著高昂的成本，這可能會阻礙其普及應用。醫療機構必須克服巨額的初始資本投資以及持續的維護和營運成本，這可能成為推廣應用的障礙，尤其對於資金預算有限的機構。此外，成功實施伽瑪刀技術需要專用設備和合格的醫務人員，這可能會限制其在某些地區和醫療機構（例如資源和訓練有素的專業人員有限的發展中地區）的普及應用。

區域趨勢

預計北美在預測期內將保持顯著的市場佔有率。這一區域主導地位可歸因於以下幾個因素：腦腫瘤發生率上升、醫療基礎設施完善、研究活動活躍、宣傳教育涵蓋範圍廣以及老年人口不斷成長。預計2023年將新增約25,000例惡性腦或脊髓腫瘤病例。該地區60歲及以上人口預計將從2019年的5,410萬增至2040年的8,080萬，將進一步推動區域市場成長，因為該年齡層罹患腦腫瘤的風險更高。

在技術進步、人口結構變化和臨床應用不斷拓展的推動下，伽瑪刀市場持續發展。隨著醫療系統優先考慮針對複雜神經系統疾病的精準、非侵入性治療方法，這些因素將推動市場持續成長。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The Gamma Knife market is experiencing robust growth at a 5.15% CAGR, projected to reach USD 571.712 million in 2031. This specialized medical device, designed for non-invasive radiosurgery targeting brain tumors and neurological conditions, is gaining prominence as healthcare systems worldwide seek precise, minimally invasive treatment alternatives for complex neurological pathologies.

Fundamental Market Drivers

Brain Tumor Prevalence

The increasing incidence of brain tumors represents a primary catalyst for Gamma Knife market expansion. The device's highly accurate guidance system and specialized collimators enable precise focusing of multiple radiation beams on target lesions, delivering effective treatment while minimizing radiation exposure to healthy brain tissue. This precision is particularly critical given that brain tumors significantly impact life expectancy, reducing it by an average of 27 years-the highest reduction among all cancer types. The technology's ability to target tumors with submillimeter accuracy makes it an increasingly preferred option for neurosurgeons and radiation oncologists managing these challenging cases.

Neurological Disorder Applications

Beyond brain tumors, Gamma Knife radiosurgery has demonstrated effectiveness across various neurological conditions, broadening its clinical utility. The technology treats selected arteriovenous malformations by focusing radiation on aberrant vessels, causing progressive closure over time. Additionally, research has explored Gamma Knife applications for movement disorders including essential tremors and Parkinson's disease. With approximately 42 million people in the U.S. population affected by movement disorders, this expanded therapeutic scope significantly amplifies market potential and positions Gamma Knife technology as a versatile tool in the neurological treatment armamentarium.

Imaging Software Integration

Advancements in imaging software have become instrumental in enhancing Gamma Knife treatment planning and execution. Modern imaging platforms enable precise delineation of target lesions, ensuring accurate targeting during procedures. Three-dimensional imaging capabilities, combined with specialized algorithms and sophisticated tools, facilitate creation of optimized treatment plans that maximize radiation delivery to pathological tissue while minimizing exposure to surrounding healthy structures. These technological refinements continue improving treatment outcomes and expanding the clinical scenarios where Gamma Knife radiosurgery represents a viable option.

Demographic Imperatives

The growing geriatric population constitutes a significant driver, as aging populations experience higher prevalence of brain tumors and neurological conditions. The global demographic shift is substantial: the proportion of people aged over 60 years worldwide is projected to increase from 12% to 22% between 2015 and 2050. Furthermore, the absolute number of individuals aged 60 years or above is estimated to grow from 1 billion in 2020 to 1.4 billion by 2031. This demographic evolution creates sustained demand for effective, minimally invasive treatment solutions that Gamma Knife technology provides.

Educational Initiatives

Increasing awareness among patients and healthcare professionals regarding Gamma Knife radiosurgery benefits is accelerating adoption rates. Educational initiatives, online resources, and information-sharing platforms have enhanced understanding of the technology's capabilities and clinical applications. Specialized training programs have emerged to support workforce development and ensure proper utilization of Gamma Knife systems, facilitating broader implementation across healthcare institutions.

Market Constraints

Despite positive growth trajectories, the Gamma Knife market faces notable challenges. The complexity and specialization of Gamma Knife systems translate to substantial costs that may impede adoption. Healthcare institutions must navigate significant initial equipment investments alongside ongoing maintenance and operational expenses, which can present barriers to integration, particularly for facilities with constrained capital budgets. Additionally, successful implementation requires specialized equipment and qualified medical personnel, potentially limiting availability in certain geographic areas or healthcare settings, especially in developing regions with limited resources or trained specialists.

Regional Dynamics

North America is positioned to maintain a significant market share during the forecast period. This regional strength stems from multiple factors: rising brain tumor incidence, robust healthcare infrastructure, active research initiatives, comprehensive awareness programs, and an expanding elderly population. Projections indicate approximately 25,000 new cases of malignant brain or spinal cord tumors in 2023. The region's population aged 60 years or above is projected to reach 80.8 million by 2040, up from 54.1 million in 2019, with this demographic showing elevated brain cancer risk, further supporting regional market growth.

The Gamma Knife market continues evolving, propelled by technological advancement, demographic shifts, and expanding clinical applications. These converging factors position the market for sustained growth as healthcare systems prioritize precise, non-invasive treatment modalities for complex neurological conditions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Gamma Knife Market Segmentation

By Disease
Brain Metastasis
Cancer
Arteriovenous Malformation
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By Distribution Channel
Online
Offline
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GAMMA KNIFE MARKET BY DISEASE

5.1. Introduction
5.2. Brain Metastasis
5.3. Cancer
5.4. Arteriovenous Malformation
5.5. Trigeminal Neuralgia
5.6. Others

6. GAMMA KNIFE MARKET BY ANATOMY

6.1. Introduction
6.2. Head
6.3. Neck
6.4. Others

7. GAMMA KNIFE MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction
7.2. Online
7.3. Offline

8. GAMMA KNIFE MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others